0001232583-17-000004.txt : 20170405
0001232583-17-000004.hdr.sgml : 20170405
20170405190028
ACCESSION NUMBER: 0001232583-17-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170403
FILED AS OF DATE: 20170405
DATE AS OF CHANGE: 20170405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolent Health, Inc.
CENTRAL INDEX KEY: 0001628908
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741]
IRS NUMBER: 320454912
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 NORTH GLEBE RD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
BUSINESS PHONE: 571-389-6000
MAIL ADDRESS:
STREET 1: 800 NORTH GLEBE RD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIGGINTON STEVE
CENTRAL INDEX KEY: 0001232583
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37415
FILM NUMBER: 17743969
MAIL ADDRESS:
STREET 1: 800 N. GLEBE ROAD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-04-03
0
0001628908
Evolent Health, Inc.
EVH
0001232583
WIGGINTON STEVE
C/O EVOLENT HEALTH, INC.
800 N GLEBE ROAD, SUITE 500
ARLINGTON
VA
22203
0
1
0
0
CEO, Valence Health
Class A Common Stock
2017-04-03
4
M
0
6000
3.84
A
364704
D
Class A Common Stock
2017-04-03
4
S
0
5300
23.11
D
359404
D
Class A Common Stock
2017-04-03
4
S
0
700
23.41
D
358704
D
Class A Common Stock Option (right to buy)
3.84
2017-04-03
4
M
0
6000
0
D
2024-04-01
Class A Common Stock
6000
423680
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016.
The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.375-$23.375, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $23.40-$23.45, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Class A Common Stock Options exercised began vesting at a rate of 25% annually beginning October 1, 2014.
/s/ Jonathan Weinberg, Attorney-in-fact
2017-04-05